Matthew Pauls
CHIEF EXECUTIVE OFFICER at Savara Inc.
Sits on 3 boards. Last updated September 28, 2026
Time on boards
- Boards served
- 3
- Current seats
- 3
- Board service
- 4 years
- Director since
- 2023
4 years of board service in total across 3 boards, counting each seat separately. Longest: Savara Inc., 2 years.
Savara Inc.
Director · CHIEF EXECUTIVE OFFICER
Pelthos Therapeutics Inc.
Director
Palvella Therapeutics Inc.
Director
Chief executive roles
Savara Inc.
· CHIEF EXECUTIVE OFFICER
Dates unknown
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jul 2, 2026 | Pelthos Therapeutics Inc. | Open-market sale | −692 | $26.00 | $17,989 |
| Jul 2, 2026 | Pelthos Therapeutics Inc. | Open-market sale | −94 | $27.36 | $2,572 |
| Apr 2, 2026 | Pelthos Therapeutics Inc. | Open-market sale | −415 | $20.52 | $8,516 |
| Apr 2, 2026 | Pelthos Therapeutics Inc. | Open-market sale | −371 | $21.36 | $7,925 |
| Dec 16, 2025 | Savara Inc. | Gift | −128,995 | — | — |
| Dec 14, 2025 | Savara Inc. | Shares withheld for tax | −195,705 | $6.92 | $1,354,279 |
| Dec 10, 2025 | Savara Inc. | Gift | −23,629 | — | — |
| Dec 10, 2025 | Pelthos Therapeutics Inc. | Gift | −9,542 | — | — |
| Oct 2, 2025 | Pelthos Therapeutics Inc. | Option exercise | +2,123 | — | — |
| Jul 2, 2025 | Pelthos Therapeutics Inc. | Option exercise | +8,493 | — | — |
| Dec 16, 2024 | Savara Inc. | Open-market sale | −54,702 | $3.31 | $181,064 |
| Dec 13, 2024 | Savara Inc. | Shares withheld for tax | −92,593 | $3.21 | $297,224 |
| Dec 12, 2024 | Savara Inc. | Grant or award | +400,000 | — | — |
| Dec 28, 2023 | Savara Inc. | Open-market sale | −84,000 | $4.71 | $395,640 |
| Dec 28, 2023 | Savara Inc. | Gift | −19,000 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.